Physical performance and daily function in people with scleroderma
Investigating the Relationship Between the Biopsychosocial Status of Individuals Diagnosed With Scleroderma and Their Physical Performance and Functionality
This project will test which questionnaires and simple physical tests best measure physical performance and daily functioning in children and adults with scleroderma.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 7 Years and up |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Çankaya, Ankara) |
| Trial ID | NCT07183072 on ClinicalTrials.gov |
What this trial studies
This observational project will enroll children (7–18) and adults with scleroderma to collect biopsychosocial data using questionnaires and a functionality application alongside simple physical performance tests. Participants will complete standardized patient-reported measures and practical tests that can be done in clinic or community settings. The study will compare results across age groups and clinical presentation to identify reliable, feasible measures of function. Findings are intended to inform which tests should be used in future research and routine monitoring.
Who should consider this trial
Good fit: Ideal participants are people diagnosed with scleroderma who are either children aged 7–18 or adults over 18 and who can attend visits at Hacettepe University.
Not a fit: Patients with advanced heart, lung, liver, or kidney disease, neurological disorders, active malignancy, or those who have been in a regular exercise program in the past three months may not benefit or be eligible.
Why it matters
Potential benefit: If successful, the project could make it easier for clinicians and researchers to track physical function and tailor care for people with scleroderma.
How similar studies have performed: Prior observational studies in adults with systemic sclerosis have identified useful functional measures, but comparable pediatric data and combined pediatric-adult comparisons are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
\*For a child diagnosed with scleroderma\* Inclusion Criteria: * Cases diagnosed with scleroderma, * Cases aged 7-18 years will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Cases that are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study \*For adults diagnosed with scleroderma\* Inclusion Criteria: * Individuals diagnosed with scleroderma, * Individuals over the age of 18 will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Individuals who are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study
Where this trial is running
Çankaya, Ankara
- Hacettepe University — Çankaya, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Orkun Tüfekçi, PT, PhD(c)
- Email: orkuntf@gmail.com
- Phone: 5319502648
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.